Global Blood Screening Market By Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA), Next Generation Sequencing, and Western Blotting), By Product (Reagent and Instrument), By End-user (Independent Clinical Laboratories, Hospital-based Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Blood Screening Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of XYZ Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Blood Screening Market Analysis and Forecast, By Segment, 2019-2033
  • 3.1. Key Findings
  • 3.2. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  • 3.3. Global Blood Screening Market Attractiveness Analysis, By Technology
    • 3.3.1. Nucleic Acid Amplification Test (NAT)
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. ELISA
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
    • 3.3.4. Next Generation Sequencing
      • 3.3.4.1. Insights
      • 3.3.4.2. Key Takeaways
    • 3.3.5. Western Blotting
      • 3.3.5.1. Insights
      • 3.3.5.2. Key Takeaways
  • 3.4. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  • 3.5. Global Blood Screening Market Attractiveness Analysis, By Product
    • 3.5.1. Reagent
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Instrument
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
  • 3.6. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  • 3.7. Global Blood Screening Market Attractiveness Analysis, By End User
    • 3.7.1. Independent Clinical Laboratories
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Hospital-based Laboratories
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Others
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
• 4. Global Blood Screening Market Analysis and Forecast, By Region, 2019-2033
  • 4.1. Key Findings
  • 4.2. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Blood Screening Market Attractiveness Analysis, By Region
• 5. North America Blood Screening Market Analysis and Forecast, 2019-2033
  • 5.1. Key Findings
  • 5.2. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  • 5.3. North America Blood Screening Market Attractiveness Analysis, By Technology
  • 5.4. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  • 5.5. North America Blood Screening Market Attractiveness Analysis, By Product
  • 5.6. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  • 5.7. North America Blood Screening Market Attractiveness Analysis, By End User
  • 5.8. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 5.9. North America Blood Screening Market Attractiveness Analysis, By Country
    • 5.9.1. The US
    • 5.9.2. Canada
• 6. Europe Blood Screening Market Analysis and Forecast, 2019-2033
  • 6.1. Key Findings
  • 6.2. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  • 6.3. Europe Blood Screening Market Attractiveness Analysis, By Technology
  • 6.4. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  • 6.5. Europe Blood Screening Market Attractiveness Analysis, By Product
  • 6.6. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  • 6.7. Europe Blood Screening Market Attractiveness Analysis, By End User
  • 6.8. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 6.9. Europe Blood Screening Market Attractiveness Analysis, By Country
    • 6.9.1. Germany
    • 6.9.2. The UK
    • 6.9.3. France
    • 6.9.4. Spain
    • 6.9.5. Italy
    • 6.9.6. Russia
    • 6.9.7. Netherland
    • 6.9.8. Rest of Europe
• 7. Asia Pacific Blood Screening Market Analysis and Forecast, 2019-2033
  • 7.1. Key Findings
  • 7.2. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  • 7.3. Asia Pacific Blood Screening Market Attractiveness Analysis, By Technology
  • 7.4. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  • 7.5. Asia Pacific Blood Screening Market Attractiveness Analysis, By Product
  • 7.6. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  • 7.7. Asia Pacific Blood Screening Market Attractiveness Analysis, By End User
  • 7.8. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 7.9. Asia Pacific Blood Screening Market Attractiveness Analysis, By Country
    • 7.9.1. China
    • 7.9.2. Japan
    • 7.9.3. South Korea
    • 7.9.4. India
    • 7.9.5. Australia
    • 7.9.6. New Zealand
    • 7.9.7. Singapore
    • 7.9.8. Thailand
    • 7.9.9. Vietnam
    • 7.9.10. Rest of Asia Pacific
• 8. Latin America Blood Screening Market Analysis and Forecast, 2019-2033
  • 8.1. Key Findings
  • 8.2. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  • 8.3. Latin America Blood Screening Market Attractiveness Analysis, By Technology
  • 8.4. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  • 8.5. Latin America Blood Screening Market Attractiveness Analysis, By Product
  • 8.6. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  • 8.7. Latin America Blood Screening Market Attractiveness Analysis, By End User
  • 8.8. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 8.9. Latin America Blood Screening Market Attractiveness Analysis, By Country
    • 8.9.1. Brazil
    • 8.9.2. Mexico
    • 8.9.3. Rest of Latin America
• 9. Middle East & Africa Blood Screening Market Analysis and Forecast, 2019-2033
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  • 9.3. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Technology
  • 9.4. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  • 9.5. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Product
  • 9.6. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  • 9.7. Middle East & Africa Blood Screening Market Attractiveness Analysis, By End User
  • 9.8. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 9.9. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Country
    • 9.9.1. South Africa
    • 9.9.2. Saudi Arabia
    • 9.9.3. UAE
    • 9.9.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
  • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Abbott
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Siemens Healthcare
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Danaher Corporation (Beckman Coulter)
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Becton Dickinson and Company
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Bio-Rad Laboratories, Inc.
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Hoffman-La Roche Ltd.
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Grifols, S.A.
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Thermo Fisher Scientific, Inc.
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. Ortho-Clinical Diagnostics, Inc.
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
    • 10.7.10. BIOMÉRIEUX
      • 10.7.10.1. Company Details
      • 10.7.10.2. Business Overview
      • 10.7.10.3. Product Portfolio
      • 10.7.10.4. Financial Insights
      • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.10.6. SWOT Analysis
      • 10.7.10.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 2. Global Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 3. Global Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 4. Global Blood Screening Market Value (US$ Mn), By Region, 2019-2033
• Table 5. North America Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 6. North America Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 7. North America Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 8. North America Blood Screening Market Value (US$ Mn), By Country, 2019-2033
• Table 9. The US Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 10. The US Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 11. The US Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 12. Canada Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 13. Canada Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 14. Canada Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 15. Europe Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 16. Europe Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 17. Europe Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 18. Europe Blood Screening Market Value (US$ Mn), By Country, 2019-2033
• Table 19. Germany Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 20. Germany Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 21. Germany Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 22. The UK Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 23. The UK Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 24. The UK Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 25. France Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 26. France Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 27. France Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 28. Spain Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 29. Spain Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 30. Spain Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 31. Italy Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 32. Italy Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 33. Italy Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 34. Russia Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 35. Russia Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 36. Russia Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 37. Netherland Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 38. Netherland Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 39. Netherland Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 40. Rest of Europe Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 41. Rest of Europe Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 42. Rest of Europe Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 43. Asia Pacific Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 44. Asia Pacific Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 45. Asia Pacific Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 46. Asia Pacific Blood Screening Market Value (US$ Mn), By Country, 2019-2033
• Table 47. China Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 48. China Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 49. China Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 50. India Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 51. India Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 52. India Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 53. Japan Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 54. Japan Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 55. Japan Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 56. South Korea Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 57. South Korea Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 58. South Korea Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 59. Australia Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 60. Australia Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 61. Australia Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 62. New Zealand Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 63. New Zealand Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 64. New Zealand Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 65. Singapore Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 66. Singapore Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 67. Singapore Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 68. Thailand Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 69. Thailand Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 70. Thailand Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 71. Vietnam Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 72. Vietnam Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 73. Vietnam Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 74. Rest of Asia Pacific Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 75. Rest of Asia Pacific Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 76. Rest of Asia Pacific Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 77. Latin America Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 78. Latin America Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 79. Latin America Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 80. Latin America Blood Screening Market Value (US$ Mn), By Country, 2019-2033
• Table 81. Brazil Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 82. Brazil Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 83. Brazil Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 84. Mexico Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 85. Mexico Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 86. Mexico Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 87. Rest of Latin America Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 88. Rest of Latin America Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 89. Rest of Latin America Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 90. Middle East & Africa Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 91. Middle East & Africa Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 92. Middle East & Africa Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 93. Middle East & Africa Blood Screening Market Value (US$ Mn), By Country, 2019-2033
• Table 94. South Africa Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 95. South Africa Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 96. South Africa Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 97. Saudi Arabia Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 98. Saudi Arabia Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 99. Saudi Arabia Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 100. UAE Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 101. UAE Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 102. UAE Blood Screening Market Value (US$ Mn), By End User, 2019-2033
• Table 103. Rest of Middle East & Africa Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
• Table 104. Rest of Middle East & Africa Blood Screening Market Value (US$ Mn), By Product, 2019-2033
• Table 105. Rest of Middle East & Africa Blood Screening Market Value (US$ Mn), By End User, 2019-2033

List of Figures

• Figure 1. Global Blood Screening Market Snapshot: Market Value (US$ Mn), 2019-2033
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Blood Screening Market
• Figure 5. Global Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
• Figure 6. Global Blood Screening Market Attractiveness Analysis, By Technology
• Figure 7. Global Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
• Figure 8. Global Blood Screening Market Attractiveness Analysis, By Product
• Figure 9. Global Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
• Figure 10. Global Blood Screening Market Attractiveness Analysis, By End User
• Figure 11. Global Blood Screening Market Analysis, By Region, 2019, 2023 and 2033
• Figure 12. Global Blood Screening Market Attractiveness Analysis, By Region
• Figure 13. North America Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
• Figure 14. North America Blood Screening Market Attractiveness Analysis, By Technology
• Figure 15. North America Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
• Figure 16. North America Blood Screening Market (US$ Mn), By ELISA, 2019-2033
• Figure 17. North America Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
• Figure 18. North America Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
• Figure 19. North America Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
• Figure 20. North America Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
• Figure 21. North America Blood Screening Market Attractiveness Analysis, By Product
• Figure 22. North America Blood Screening Market (US$ Mn), by Reagent, 2019-2033
• Figure 23. North America Blood Screening Market (US$ Mn), by Instrument, 2019-2033
• Figure 24. North America Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
• Figure 25. North America Blood Screening Market Attractiveness Analysis, By End User
• Figure 26. North America Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
• Figure 27. North America Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
• Figure 28. North America Blood Screening Market (US$ Mn), By Others, 2019-2033
• Figure 29. North America Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
• Figure 30. North America Blood Screening Market Attractiveness Analysis, By Country
• Figure 31. Europe Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
• Figure 32. Europe Blood Screening Market Attractiveness Analysis, By Technology
• Figure 33. Europe Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
• Figure 34. Europe Blood Screening Market (US$ Mn), By ELISA, 2019-2033
• Figure 35. Europe Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
• Figure 36. Europe Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
• Figure 37. Europe Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
• Figure 38. Europe merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
• Figure 39. Europe Blood Screening Market Attractiveness Analysis, By Product
• Figure 40. Europe Blood Screening Market (US$ Mn), by Reagent, 2019-2033
• Figure 41. Europe Blood Screening Market (US$ Mn), by Instrument, 2019-2033
• Figure 42. Europe Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
• Figure 43. Europe Blood Screening Market Attractiveness Analysis, By End User
• Figure 44. Europe Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
• Figure 45. Europe Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
• Figure 46. Europe Blood Screening Market (US$ Mn), By Others, 2019-2033
• Figure 47. Europe Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
• Figure 48. Europe Blood Screening Market Attractiveness Analysis, By Country
• Figure 49. Asia Pacific Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
• Figure 50. Asia Pacific Blood Screening Market Attractiveness Analysis, By Technology
• Figure 51. Asia Pacific Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
• Figure 52. Asia Pacific Blood Screening Market (US$ Mn), By ELISA, 2019-2033
• Figure 53. Asia Pacific Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
• Figure 54. Asia Pacific Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
• Figure 55. Asia Pacific Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
• Figure 56. Asia Pacific merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
• Figure 57. Asia Pacific Blood Screening Market Attractiveness Analysis, By Product
• Figure 58. Asia Pacific Blood Screening Market (US$ Mn), by Reagent, 2019-2033
• Figure 59. Asia Pacific Blood Screening Market (US$ Mn), by Instrument, 2019-2033
• Figure 60. Asia Pacific Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
• Figure 61. Asia Pacific Blood Screening Market Attractiveness Analysis, By End User
• Figure 62. Asia Pacific Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
• Figure 63. Asia Pacific Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
• Figure 64. Asia Pacific Blood Screening Market (US$ Mn), By Others, 2019-2033
• Figure 65. Asia Pacific Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
• Figure 66. Asia Pacific Blood Screening Market Attractiveness Analysis, By Country
• Figure 67. Latin America Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
• Figure 68. Latin America Blood Screening Market Attractiveness Analysis, By Technology
• Figure 69. Latin America Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
• Figure 70. Latin America Blood Screening Market (US$ Mn), By ELISA, 2019-2033
• Figure 71. Latin America Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
• Figure 72. Latin America Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
• Figure 73. Latin America Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
• Figure 74. Latin America merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
• Figure 75. Latin America Blood Screening Market Attractiveness Analysis, By Product
• Figure 76. Latin America Blood Screening Market (US$ Mn), by Reagent, 2019-2033
• Figure 77. Latin America Blood Screening Market (US$ Mn), by Instrument, 2019-2033
• Figure 78. Latin America Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
• Figure 79. Latin America Blood Screening Market Attractiveness Analysis, By End User
• Figure 80. Latin America Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
• Figure 81. Latin America Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
• Figure 82. Latin America Blood Screening Market (US$ Mn), By Others, 2019-2033
• Figure 83. Latin America Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
• Figure 84. Latin America Blood Screening Market Attractiveness Analysis, By Country
• Figure 85. Middle East & Africa Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
• Figure 86. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Technology
• Figure 87. Middle East & Africa Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
• Figure 88. Middle East & Africa Blood Screening Market (US$ Mn), By ELISA, 2019-2033
• Figure 89. Middle East & Africa Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
• Figure 90. Middle East & Africa Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
• Figure 91. Middle East & Africa Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
• Figure 92. Middle East & Africa merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
• Figure 93. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Product
• Figure 94. Middle East & Africa Blood Screening Market (US$ Mn), by Reagent, 2019-2033
• Figure 95. Middle East & Africa Blood Screening Market (US$ Mn), by Instrument, 2019-2033
• Figure 96. Middle East & Africa Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
• Figure 97. Middle East & Africa Blood Screening Market Attractiveness Analysis, By End User
• Figure 98. Middle East & Africa Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
• Figure 99. Middle East & Africa Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
• Figure 100. Middle East & Africa Blood Screening Market (US$ Mn), By Others, 2019-2033
• Figure 101. Middle East & Africa Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
• Figure 102. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Country